Beneath is Validea’s guru basic report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru methods we observe, VRTX charges highest utilizing our P/B Growth Investor mannequin based mostly on the printed technique of Partha Mohanram. This progress mannequin seems to be for low book-to-market shares that exhibit traits related to sustained future progress.
VERTEX PHARMACEUTICALS INC (VRTX) is a large-cap worth inventory within the Biotechnology & Medicine trade. The score utilizing this technique is 77% based mostly on the agency’s underlying fundamentals and the inventory’s valuation. A rating of 80% or above usually signifies that the technique has some curiosity within the inventory and a rating above 90% usually signifies sturdy curiosity.
The next desk summarizes whether or not the inventory meets every of this technique’s exams. Not all standards within the under desk obtain equal weighting or are impartial, however the desk supplies a quick overview of the sturdy and weak factors of the safety within the context of the technique’s standards.
| BOOK/MARKET RATIO: | PASS |
| RETURN ON ASSETS: | PASS |
| CASH FLOW FROM OPERATIONS TO ASSETS: | PASS |
| CASH FLOW FROM OPERATIONS TO ASSETS VS. RETURN ON ASSETS: | PASS |
| RETURN ON ASSETS VARIANCE: | PASS |
| SALES VARIANCE: | PASS |
| ADVERTISING TO ASSETS: | FAIL |
| CAPITAL EXPENDITURES TO ASSETS: | PASS |
| RESEARCH AND DEVELOPMENT TO ASSETS: | FAIL |
Detailed Evaluation of VERTEX PHARMACEUTICALS INC
Extra Data on Partha Mohanram
About Partha Mohanram: Typically the perfect investing methods do not come from the world of investing. Typically analysis that adjustments the investing world can come from the halls of academia. Partha Mohanram is a good instance of this. Whereas educational analysis has proven that worth investing works over time, it has discovered the other for progress investing. Mohanram turned that analysis on its head by growing a progress mannequin that produced vital market outperformance. His analysis paper “Separating Winners from Losers amongst Low E book-to-Market Shares utilizing Monetary Assertion Evaluation” appeared on the standards that can be utilized to separate progress shares that proceed their upward trajectory from those who do not. Mohanram is presently the John H. Watson Chair in Worth Investing on the College of Toronto and was beforehand an Affiliate Professor on the Columbia Enterprise Faculty.
Extra Analysis Hyperlinks
About Validea: Validea is aninvestment researchservice that follows the printed methods of funding legends. Validea affords each inventory evaluation and mannequin portfolios based mostly on gurus who’ve outperformed the market over the long-term, together with Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For extra details about Validea, click here
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.
